MedTrace Logo

Investigation of Milk Peptides on Postprandial Blood Glucose Profile

NCT03932695 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2019-05-14

No results posted yet for this study

Summary

Aim of the study is to investigate the effect of two different dosages of milk peptides on postprandial blood glucose profile in prediabetic subjects compared to placebo. This will be investigated in a cross-over double blind randomized placebo controlled study design. Additionally, long term effects on glucose status, insulin sensitivity and postprandial blood glucose profile will be investigated in a follow up 6-week open label phase with the low dose only.

Conditions

  • Postprandial Hyperglycemia

Interventions

DIETARY_SUPPLEMENT

Low dose milk peptide

what is the effect of milk peptides 1400mg on postprandial glycemia after a meal rich in carbohydrates (75g)

DIETARY_SUPPLEMENT

High Dose milk peptide

what is the effect of milk peptides 2800mg on postprandial glycemia after a meal rich in carbohydrates (75g)

DIETARY_SUPPLEMENT

Placebo

what is the effect of placebo on postprandial glycemia after a meal rich in carbohydrates (75g)

Sponsors & Collaborators

  • Ingredia S.A.

    lead INDUSTRY

Principal Investigators

  • Audrey BOULIER, MD · Ingredia S.A.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-26
Primary Completion
2019-02-20
Completion
2019-04-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03932695 on ClinicalTrials.gov